Latest news
Kali Therapeutics Receives US FDA Clearance for KT501 Investigational New Drug Application
The US Food and Drug Administration (FDA) has cleared Kali Therapeutics, a clinical-stage biotechnology company pioneering next-generation immune-resetting and...
Thryv Therapeutics licences a new class of SGK1 inhibitors from Spain’s CSIC and Universidad Autónoma de Madrid, extending its platform into neurodegenerative disease
Thryv Therapeutics has entered into an exclusive, worldwide, royalty-bearing patent and know-how license agreement with the Spanish National Research...
Lubrizol targets drug delivery challenges at CPHI Milan
Lubrizol will showcase its portfolio of multifunctional excipients at CPHI Milan (6-8 October), and demonstrate how they solve diverse...
FairJourney Bio delivers antibody engineering for novel tumour-conditional IL-12 therapeutic approach that unlocks the potential of localised cytokine activation
FairJourney Bio, a global antibody discovery expert, has announced the publication of a peer-reviewed study in mAbs describing a novel...
Taysha Gene Therapies and Catalent expand strategic partnership to include future commercial manufacturing support of TSHA-102 gene therapy for Rett syndrome
Taysha Gene Therapies, a clinical-stage biotechnology company focused on developing adeno-associated virus (AAV)-based gene therapies for rare, monogenic diseases...
Aurisco Pharmaceutical’s Chinese manufacturing plant gets green light from US Food and Drug Administration
Aurisco Pharmaceutical announced that its manufacturing site in Yangzhou, China, has passed a US Food and Drug Administration (USFDA) pre-approval...
Veeva Vault CRM selected by Eli Lilly and Company
Veeva Systems has announced that Eli Lilly and Company (Lilly) has committed to Veeva Vault CRM globally.
Vault CRM is part of the...
Adneuris Therapeutics grants exclusive license to Maruishi Pharmaceutical to advance Cebranopadol in Japan and South Korea
Adneuris Therapeutics has entered into an exclusive license agreement with Maruishi Pharmaceutical Co., Ltd., a privately held, perioperative and...
Aureka Biotechnologies raises US$100 million to build a biological world model for drug discovery
Aureka Biotechnologies has closed financing of US$100 million.
The company will direct proceeds primarily toward research and large-scale training of...
Oncoinvent announces publication of normal tissue dosimetry results in Journal of Nuclear Medicine
Oncoinvent, a biotech company developing a receptor-independent alpha radiopharmaceutical to eradicate cancer cells in the abdominal cavity after surgery...
US FDA approves Takeda’s Orzeyful (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1
The US Food and Drug Administration (FDA) has approved Takeda’s Orzeyful (oveporexton), an oral orexin receptor 2 (OX2R) agonist,...
Lilly’s olomorasib receives US FDA breakthrough therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to Eli Lilly and Company’s olomorasib as...
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -
Popular